Brolucizumab: an evolution in treatment for neovascular age-related macular degeneration

MLA

Kimberly Spooner, et al. “Brolucizumab: An Evolution in Treatment for Neovascular Age-Related Macular Degeneration.” Expert Review of Ophthalmology, vol. 15, Mar. 2020, pp. 71–81. EBSCOhost, https://doi.org/10.1080/17469899.2020.1735363.

APA

Kimberly Spooner, Ee Lin Ong, Thomas Hong, & Andrew Chang. (2020). Brolucizumab: an evolution in treatment for neovascular age-related macular degeneration. Expert Review of Ophthalmology, 15, 71–81. https://doi.org/10.1080/17469899.2020.1735363

Chicago

Kimberly Spooner, Ee Lin Ong, Thomas Hong, and Andrew Chang. 2020. “Brolucizumab: An Evolution in Treatment for Neovascular Age-Related Macular Degeneration.” Expert Review of Ophthalmology 15 (March): 71–81. doi:10.1080/17469899.2020.1735363.